Brought to you by 
Dade and Hoechst's Behring to merge
13 Jul 1999
Executive Summary
Dade and Hoechst's Behring Diagnostics division will merge in a stock transaction. Hoechst will own 32.5% of the new company, which will be called Dade Behring Inc.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com